By www.reliablebusinessarena.com
Global Ependymoma Market Size, Status And Forecast 2024-2031 Story
108
$ 3900
Ependymoma Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Eli Lilly
Astellas
DNAtrix
Advantagene
Burzynski Research Institute
Direct Therapeutics
Cellectar Biosciences
Amgen
Boehringer Ingelheim
Bristol-Myers Squibb
Celgene
Novartis
NewLink Genetics